skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 4,342  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
Material Type:
Article
Add to My Research

Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension

The New England journal of medicine, 2021-09, Vol.385 (14), p.1268-1279 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2111437 ;PMID: 34491661

Full text available

2
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
Material Type:
Article
Add to My Research

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

The New England journal of medicine, 2021-01, Vol.384 (4), p.325-334 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2008470 ;PMID: 33440084

Full text available

3
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
Material Type:
Article
Add to My Research

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

The New England journal of medicine, 2015-11, Vol.373 (22), p.2103-2116 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1511939 ;PMID: 26551272

Full text available

4
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control
Material Type:
Article
Add to My Research

Final Report of a Trial of Intensive versus Standard Blood-Pressure Control

The New England journal of medicine, 2021-05, Vol.384 (20), p.1921-1930 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1901281 ;PMID: 34010531

Full text available

5
Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage
Material Type:
Article
Add to My Research

Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage

The New England journal of medicine, 2016-09, Vol.375 (11), p.1033-1043 [Peer Reviewed Journal]

Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1603460 ;PMID: 27276234

Full text available

6
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?
Material Type:
Article
Add to My Research

COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?

JAMA, 2020-05, Vol.323 (18), p.1769 [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://jamanetwork.com/journals/jama/pages/coronavirus-alert . ;DOI: 10.1001/jama.2020.4812

Digital Resources/Online E-Resources

7
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis
Material Type:
Article
Add to My Research

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis

The Lancet (British edition), 2016-01, Vol.387 (10017), p.435-443 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 30, 2016 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(15)00805-3 ;PMID: 26559744 ;CODEN: LANCAO

Full text available

8
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension
Material Type:
Article
Add to My Research

Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension

The New England journal of medicine, 2023-02, Vol.388 (5), p.395-405 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2023 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2213169 ;PMID: 36342143

Full text available

9
Hypertension Management in Older and Frail Older Patients
Material Type:
Article
Add to My Research

Hypertension Management in Older and Frail Older Patients

Circulation research, 2019-03, Vol.124 (7), p.1045-1060 [Peer Reviewed Journal]

2019 American Heart Association, Inc. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/CIRCRESAHA.118.313236 ;PMID: 30920928

Full text available

10
Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study
Material Type:
Article
Add to My Research

Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study

BMJ (Online), 2018-10, Vol.363, p.k4209 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2018 BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2018 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.k4209 ;PMID: 30355745

Full text available

11
Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial
Material Type:
Article
Add to My Research

Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial

BMJ (Online), 2021-01, Vol.372, p.m4858 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m4858 ;PMID: 33468518

Full text available

12
Shared Risk Factors in Cardiovascular Disease and Cancer
Material Type:
Article
Add to My Research

Shared Risk Factors in Cardiovascular Disease and Cancer

Circulation (New York, N.Y.), 2016-03, Vol.133 (11), p.1104-1114 [Peer Reviewed Journal]

2016 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2016 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.115.020406 ;PMID: 26976915

Full text available

13
Polypill with or without Aspirin in Persons without Cardiovascular Disease
Material Type:
Article
Add to My Research

Polypill with or without Aspirin in Persons without Cardiovascular Disease

The New England journal of medicine, 2021-01, Vol.384 (3), p.216-228 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2028220 ;PMID: 33186492

Full text available

14
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
Material Type:
Article
Add to My Research

Antihypertensive drug therapy for mild to moderate hypertension during pregnancy

Cochrane database of systematic reviews, 2007-01 (1), p.CD002252 [Peer Reviewed Journal]

EISSN: 1469-493X ;DOI: 10.1002/14651858.CD002252.pub2 ;PMID: 17253478

Full text available

15
Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects
Material Type:
Article
Add to My Research

Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects

Circulation (New York, N.Y.), 2019-07, Vol.140 (4), p.270-279 [Peer Reviewed Journal]

2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2019 The Authors. 2019 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.118.038814 ;PMID: 31234639

Full text available

16
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
Material Type:
Article
Add to My Research

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

The Lancet (British edition), 2022-12, Vol.400 (10367), p.1927-1937 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)02034-7 ;PMID: 36356632

Full text available

17
Renin–Angiotensin System Inhibition in Advanced Chronic Kidney Disease
Material Type:
Article
Add to My Research

Renin–Angiotensin System Inhibition in Advanced Chronic Kidney Disease

The New England journal of medicine, 2022-12, Vol.387 (22), p.2021-2032 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2210639 ;PMID: 36326117

Full text available

18
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
Material Type:
Article
Add to My Research

Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease

The New England journal of medicine, 2016-05, Vol.374 (21), p.2032-2043 [Peer Reviewed Journal]

Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1600177 ;PMID: 27039945

Full text available

19
Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study
Material Type:
Article
Add to My Research

Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study

Hypertension (Dallas, Tex. 1979), 2021-09, Vol.78 (3), p.591-603 [Peer Reviewed Journal]

ISSN: 0194-911X ;EISSN: 1524-4563 ;DOI: 10.1161/HYPERTENSIONAHA.120.16667 ;PMID: 34304580

Full text available

20
Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertension
Material Type:
Article
Add to My Research

Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertension

Diabetes care, 2015-03, Vol.38 (3), p.420-428 [Peer Reviewed Journal]

2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Mar 2015 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc14-1096 ;PMID: 25271206 ;CODEN: DICAD2

Full text available

Results 1 - 20 of 4,342  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (4,073)

Refine My Results

Creation Date 

From To
  1. Before 1976  (108)
  2. 1976 To 1987  (302)
  3. 1988 To 1999  (696)
  4. 2000 To 2012  (1,899)
  5. After 2012  (1,338)
  6. More options open sub menu

Resource Type 

  1. Articles  (4,327)
  2. magazinearticle  (12)
  3. Newsletter Articles  (3)
  4. More options open sub menu

Language 

  1. English  (4,127)
  2. Japanese  (386)
  3. Spanish  (58)
  4. French  (57)
  5. German  (54)
  6. Portuguese  (38)
  7. Swedish  (31)
  8. Norwegian  (18)
  9. Russian  (12)
  10. Polish  (5)
  11. Hungarian  (2)
  12. Chinese  (2)
  13. Croatian  (2)
  14. Italian  (1)
  15. Serbian  (1)
  16. Turkish  (1)
  17. More options open sub menu

Searching Remote Databases, Please Wait